Trade Summary

1 week ago, Evnin Luke, serving as Dir at Werewolf Therapeutics, Inc. (HOWL), sold 291,283 shares at $0.64 per share, for a total transaction value of $185,221.00. Following this transaction, Evnin Luke now holds 2,550,674 shares of HOWL.

This sale represents a 10.00% decrease in Evnin Luke's stake in the company. This is considered a high-conviction trade given the significant change in ownership.

The trade was executed on Monday, December 22, 2025 and publicly disclosed via SEC Form 4 filing on Monday, December 29, 2025, 7 days after the trade was made.

Werewolf Therapeutics, Inc. operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider selling activity in this sector can provide valuable signals about industry trends and company-specific developments.